NYSE · AUNA
Auna SA
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for AUNA: Nov 17, 2026
Auna SA Class A Ordinary Shares is expected to report earnings on 11/17/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $0.27. The reported EPS for the same quarter last year was $0.2.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.27 | $0.27 | $0.26 | 2 |
| Dec 2026 | $0.22 | $0.26 | $0.19 | 2 |
| Mar 2027 | $0.24 | $0.25 | $0.23 | 2 |
| Jun 2027 | $0.27 | $0.30 | $0.23 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
MarketBeat · The Motley Fool · Zacks- MarketBeat · Oct 23, 8:02 AM EDTAuna Investor Day: Colombia Pressure Prompts 2026 EBITDA Growth ResetAuna (NYSE:AUNA) outlined its strategy for expanding an integrated healthcare platform across Latin America at its 2026 Investor Day, while also lowering expectations for adjusted EBITDA growth this year due to reimbursement and contracting pressures in Colombia. President and E
- The Motley Fool · Aug 25, 6:58 PM EDTAuna (AUNA) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 19, 9:03 AM EDTAuna Q2 Earnings Call HighlightsAuna (NYSE:AUNA) reported second-quarter results marked by continued revenue growth, improving cash generation and a sequential recovery in patient volumes in Mexico, though adjusted EBITDA declined amid margin pressures, talent investments and billing-related penalties in Peru.
- Zacks · Aug 18, 6:10 PM EDTAuna S.A. (AUNA) Q2 Earnings Miss EstimatesAuna S.A. (AUNA) delivered earnings and revenue surprises of -42.31% and +2.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 14, 5:30 PM EDTCerenome (CNSY) Reports Q2 Loss, Misses Revenue EstimatesCerenome (CNSY) delivered earnings and revenue surprises of -36.46% and -60.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 13, 9:45 AM EDTFate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue EstimatesFate Therapeutics (FATE) delivered earnings and revenue surprises of +10.71% and +108.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 11, 10:00 AM EDTAuna S.A. (AUNA) Expected to Beat Earnings Estimates: Should You Buy?Auna S.A. (AUNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Aug 10, 8:45 AM EDTSurgery Partners (SGRY) Q2 Earnings and Revenues Beat EstimatesSurgery Partners (SGRY) delivered earnings and revenue surprises of +400.00% and +1.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 5:40 PM EDTProgyny (PGNY) Q2 Earnings and Revenues Beat EstimatesProgyny (PGNY) delivered earnings and revenue surprises of +7.84% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 6:10 PM EDTSolventum (SOLV) Q2 Earnings and Revenues Top EstimatesSolventum (SOLV) delivered earnings and revenue surprises of +33.51% and +2.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 4, 7:25 AM EDTRevvity (RVTY) Q2 Earnings and Revenues Surpass EstimatesRevvity (RVTY) delivered earnings and revenue surprises of +14.63% and +3.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 29, 7:30 AM EDTAvantor, Inc. (AVTR) Beats Q2 Earnings and Revenue EstimatesAvantor (AVTR) delivered earnings and revenue surprises of +10.53% and +4.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Auna SA from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.